Matthew L. Sherman, MD

Deciphera Pharmaceuticals, LLC
Waltham, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 27 - SAFETY AND EFFICACY UPDATES FROM A PHASE 1 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM  

• Paper 61 - INSIGHT: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF RIPRETINIB VS SUNITINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR PREVIOUSLY TREATED WITH IMATINIB WITH KIT EXON 11+17/18 MUTATIONS

  Saturday, November 4, 2023
  9:00 AM – 10:00 AM